Rimactazid 150/75 150mg. 75mg Tablet
PDF Leaflet Revision Date: 02 May 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Pulmonary tuberculosis in the continuous phase of treatment.
Dosage (summary)
Rifampicin 10 mg/kg (max 600 mg), Isoniazid 5 mg/kg (max 300 mg) daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Diabetes mellitus
- Chronic alcoholism
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; caution advised.
Key Drug Interactions
- Halothane
- Ketoconazole
- Phenytoin
- Warfarin
- Oral contraceptives
Contraindications
- Hypersensitivity to rifamycins or isoniazid
- Jaundice
- Liver damage
Common side effects
- Liver dysfunction
- Nausea
- Vomiting
- Skin rashes
- Thrombocytopenia
Counselling Points
- Monitor for signs of liver damage
- Avoid alcohol
- Use non-hormonal contraceptives
Serious warnings
- Monitor liver function
- Risk of severe hepatitis
- May exacerbate convulsive disorders
Important Disclaimer
The Rimactazid 150/75 150mg. 75mg Tablet professional information leaflet below is the property of Sandoz and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
